Company Information

Global Healthcare Network

GHN Pharma AB GHN (Global Healthcare Network)

GHN Pharma Metabolic

Voices Across Continents: “Future Trends in Pharma & Biotech – GHN 2025”

Voices Across Continents: “Future Trends in Pharma & Biotech – GHN 2025”. The culmination of interviews and insights from 17 senior GHN Members across five continents.

A Journey Across Five Decades in Pharma – Featured on Growth Cast

In Growth Cast – Insights for B2B Leaders, we reflect on more than 90 years of combined experience in the international pharmaceutical industry, sharing insights on leadership, collaboration and the changes shaping pharma.

pharmaand GmbH and GHN Pharma Nordic AB Announce Collaboration Extension and Expansion

GHN Pharma and SmartPractice Partner in Nordic Markets

SmartPractice announces GHN Pharma as its new distribution partner from January 1, 2024, bringing patch testing products and educational resources to clinicians in the Nordic markets.

GHN Pharma Nordic and Welcare Industries increases the cooperation regarding the Jalosome line with JALOSOME® ORAL BARRIER.

GHN Pharma Nordic and Welcare Industries expand their collaboration with Jalosome® Oral Barrier, adding an oral care medical device to the existing Jalosome® Soothing Gel range.

GHN Healthy Planet, a Guide to Health Care, Part 4 the Nordics

Discover the Nordic region in Part 4 of GHN’s Healthy Planet guide, continuing the Helping You Globalise series covering healthcare markets around the world.

GHN Pharma Metabolic AB and Pharmaelle Srl, today announced a strategic agreement to launch Aldixyl® in Denmark, Finland, Island, Norway and Sweden.

GHN Pharma Metabolic AB and Pharmaelle Srl announce a strategic agreement to introduce Aldixyl® in the Nordic markets, expanding their collaboration in rare metabolic diseases.

GHN Pharma Nordic AB, and Welcare Industries SpA, today announced a strategic agreement to launch the Jalosome® line in Denmark, Finland, Island, Norway and Sweden.

GHN Pharma Nordic AB and Welcare Industries SpA announce a strategic agreement to introduce the Jalosome® line in the Nordic markets, expanding their collaboration in skin care.

An introduction to GHN Pharma Nordic

GHN Group brings together global expertise and local knowledge through Global Healthcare Network, GHN Pharma Nordic and GHN Pharma Metabolic.